Norway· NO-ID_180AC68E-5CE9-4F9B-A87D-BFE46249B127
Cluvot
A coagulation factor xiii product containing human coagulation factor xiii, registered in Norway by CSL Behring GmbH (2). The same ATC class is registered in 9 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Coagulation factor xiii is registered in 9 of 19 countries.
Countries holding a registration under ATC B02BD07 (coagulation factor xiii), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 6 of them publish a price we can compare per daily dose
Coagulation factor xiii · ATC B02BD07
9 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Human Coagulation Factor Xiii
- Manufacturer
- CSL Behring GmbH (2)
- Country
- Norway (NO)
- ATC code
- B02BD07
- ATC class
- Coagulation factor XIII
- Defined daily dose
- 3.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_180AC68E-5CE9-4F9B-A87D-BFE46249B127
- no_varenummer4538091NOK 24232.2
- gtin7046264538098
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
2 interactions on record for coagulation factor xiii.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Coagulation factor xiii · interactions on record
2 records
- 2 severe
Most severe, free to view
- CarfilzomibL01XG02severe
- CarfilzomibL01XX45severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B02BD07
Coagulation factor xiii, as other registers publish it.
- FinlandCluvotAbacus Medicine A/S
- NorwayCluvotCSL Behring GmbH (2)
- DenmarkCluvotCSL Behring GmbH
- FinlandCluvotCSL Behring GmbH
- FinlandCluvotCSL Behring GmbH
- DenmarkCluvotCSL Behring GmbH
- NetherlandsCluvot 1250 IE, poeder en oplosmiddel voor oplossing voor injectie of infusieCSL Behring GmbH
- BelgiumCluvot 1250 IUCSL Behring
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6b22e9eb-ea36-4954-91c8-a57625718888 GET /v1/drugs/6b22e9eb-ea36-4954-91c8-a57625718888?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og væske til injeksjons-/infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Koagulasjonsfaktor XIII",
"merkevare_id": "ID_180AC68E-5CE9-4F9B-A87D-BFE46249B127",
"name_form_strength": "Cluvot pulv+væske til inj/inf oppl 1250 IU",
"prescription_group": "C"
}See everything about coagulation factor xiii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.